Debevoise & Plimpton is advising Tarsadia Investments on the transaction. Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) announced that it plans to organize and simplify its corporate structure,...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here